Premium
Assessment of the improvement of the quality of vision after Meibopatch© treatment, with OQAS and Hartmann‐Shack aberrometry in patients with meibomian gland dysfunction
Author(s) -
DUPONT L,
NOCHEZ Y,
PISELLA PJ,
COCHENER B,
GICQUEL JJ
Publication year - 2012
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2012.t059.x
Subject(s) - meibomian gland , medicine , eyelid , ophthalmology
Purpose To assess optical quality before and after treatment with Meibopatch© (eyelid‐warming device) in patient with mild and severe Meibomian gland dysfunction. Methods The Meibopatch© was applied for 5 minutes twice a day for one month to 20 eyes of 10 patients who exhibited dry‐eye symptoms (OSDI), decreased tear film break‐up time (TFBUT) due to altered meibomian gland secretions. We examined TFBUT, meibomian gland secretions, dry‐eye symptoms, and assessed optical quality with OQAS (MTF and OSI) and Hartmann‐Schack (RMS) aberrometry before, 15 days and 1 month after treatment. Results We have observed a significant improvement of the BUT, OSDI, Meibomian gland secretion quality, MTF and OSI after treatment. Conclusion The Meibopatch © eyelids warming device improved dry‐eye symptoms, TFBUT and meibomian gland secretion quality. Our study showed also a significant improvement of both MTF and OSI.